These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1308035)

  • 1. Diabetic peripheral neuropathy.
    Kayal A
    J Assoc Physicians India; 1992 Sep; 40(9):638. PubMed ID: 1308035
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of diabetic neuropathy with pentoxifylline: case report.
    Kalmansohn RB; Kalmansohn RW; Markham CH; Schiff DL
    Angiology; 1988 Apr; 39(4):371-4. PubMed ID: 3364803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline and diabetic neuropathy.
    Sainati SM
    Diabetes Care; 1991 Oct; 14(10):930. PubMed ID: 1812883
    [No Abstract]   [Full Text] [Related]  

  • 4. Pentoxifylline and diabetic neuropathy.
    Cohen KL; Harris S
    Ann Intern Med; 1987 Oct; 107(4):600-1. PubMed ID: 3631805
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing the effects of pentoxifylline (Trental) on diabetic neurotrophic foot ulcers.
    Adler PF
    J Foot Surg; 1991; 30(3):300-3. PubMed ID: 1875009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pentoxifylline and pentosan polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus.
    Laczy B; Cseh J; Mohás M; Markó L; Tamaskó M; Koszegi T; Molnár GA; Wagner Z; Wagner L; Wittmann I
    Acta Diabetol; 2009 Jun; 46(2):105-11. PubMed ID: 18839054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of clonidine and pentoxifylline in short-term therapy of diabetic peripheral neuropathy.
    Cohen KL; Lucibello FE; Chomiak M
    Diabetes Care; 1990 Oct; 13(10):1074-7. PubMed ID: 2209305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of diabetic subjects with sensory neuropathy.
    Seshiah V; Venkataraman S; Ganesan VS; Hariharan RS; Sundaram A; Manjula N
    J Assoc Physicians India; 1988 Aug; 36(8):527-8. PubMed ID: 3246514
    [No Abstract]   [Full Text] [Related]  

  • 9. The management of oral mexiletine and intravenous lidocaine to treat chronic painful symmetrical distal diabetic neuropathy.
    Ackerman WE; Colclough GW; Juneja MM; Bellinger K
    J Ky Med Assoc; 1991 Oct; 89(10):500-1. PubMed ID: 1744511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic neuropathy--choices of treatment.
    Bruckner I; Bustan C; Adamescu E; Dobjanschi C
    Rom J Intern Med; 2002; 40(1-4):53-60. PubMed ID: 15526540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkalaemia, ketoacidosis and subcutaneous or intravenous insulin infusions.
    MacRury SM; Small M; MacCuish AC
    Diabetes Res; 1987 Jul; 5(3):153-5. PubMed ID: 3117474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is pentoxifylline the drug of the decade?
    Ely H
    J Am Acad Dermatol; 1994 Apr; 30(4):639-42. PubMed ID: 8157792
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the effectiveness of Pentoxifylline in the treatment of retinal vein thrombosis. Preliminary report].
    Poppe E; Grochowski J
    Klin Oczna; 1991 Sep; 93(9):257-8. PubMed ID: 1816459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of the effect of buflomedil on peripheral neuropathy in diabetic patients].
    Zhou M; Lei MX
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):239-40. PubMed ID: 12536693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences in treating diabetic peripheral neuropathy with traditional Chinese medicine.
    WEI ZX
    Chin J Integr Med; 2008 Dec; 14(4):248-50. PubMed ID: 19082794
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic strategies in diabetic neuropathy. Pathogenetically founded therapeutic approaches in peripheral, sensory, symmetrical neuropathy].
    Luft D
    Med Klin (Munich); 1996 May; 91(5):295-301. PubMed ID: 8709907
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy.
    Wright M; Hill S; Slaney MA
    Med J Aust; 1994 Jan; 160(1):45. PubMed ID: 8123141
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug therapy of symptoms in peripheral diabetic neuropathy. Tricyclic antidepressive agents and other drugs].
    Sindrup SH
    Ugeskr Laeger; 1990 Feb; 152(8):554-6. PubMed ID: 2309368
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy.
    Florkowski CM
    Med J Aust; 1993 Nov; 159(10):711-2. PubMed ID: 8110237
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
    Akahori H; Takamura T; Hayakawa T; Ando H; Yamashita H; Kobayashi K
    Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.